Product Name | NebuSelect™ Recombinant Human CDH17/Cadherin 17 Domain 3&4, mFc-tag |
---|---|
Catalog Number | NBL-240796 |
Alias/Synonyms | CDH17/Cadherin 17 Domain 3&4 |
Appearance | see COA |
Molecule Weight | Val245-Phe449 |
CAS | N/A |
Solubility | Water Soluble |
Storage | Short term 4℃; Long term -20℃. |
Shelf Life | 2 years |
Additional info 1 | Q12864 |
Additional info 2 |
Catalog Numbe | Size | Price | Inventory Level | |
NBL-240796-100ug | 100ug | Inquire | Inquire | |
NBL-240796-1mg | 1mg | Inquire | Inquire | |
NBL-240796-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human CDH17/Cadherin 17 Domain 3&4, mFc-tag
Catalog#:
NBL-240796
Description:
NebuSelect™ Recombinant Human CDH17/Cadherin 17 Domain 3&4, mFc-tag(Cat#NBL-240796) is expressed in HEK293 with mFc (IgG1) tag at the C-Terminus.It contains Val245-Phe449.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 49.16 kDa. Due to glycosylation, the protein migrates to 55-70 kDa based on Bis-Tris PAGE result.
Target Name:
CDH17/Cadherin 17 Domain 3&4
Target Information:
Liver-intestine cadherin (CDH17) has been known to function as a tumor stimulator and diagnostic marker for almost two decades.In vivo studies showed CDH17 knockout resulted in apoptotic PC tumor death through activating caspase-3 activity. Taken together, CDH17 functions as an oncogenic molecule critical to PC growth by regulating tumor apoptosis signaling pathways and CDH17 could be targeted to develop an anti-PC therapeutic approach.
Amino Acid Sequence:
Val245-Phe449
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.